This episode currently has no reviews.
Submit ReviewThis week Jeremy talks to Dr. Neil Thakur about The ALS Association’s comments to the FDA urging them to approve tofersen, a gene therapy targeting SOD1 mutations. He then digs into the tofersen clinical trials with lead investigator Dr. Timothy Miller.
For more information on genetic testing and counseling go to https://www.als.org/understanding-als/who-gets-als/genetic-testing
This episode is brought to you by The ALS Association in partnership with CitizenRacecar.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review